Treatment outcomes of multidrug-resistant TB with selective use of new drugs

被引:4
作者
Kwon, Y-S. [1 ]
Shin, J. E. [2 ]
Kang, H. [3 ]
Jeon, D. [4 ]
Yim, J-J. [5 ]
Shim, T. S. [2 ,6 ]
机构
[1] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Internal Med, Med Sch, Gwangju, South Korea
[2] Univ Ulsan, Asan Med Ctr, Div Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[3] Masan Natl TB Hosp, Dept Chest Med, Masan, South Korea
[4] Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Div Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[6] Univ Ulsan, Asan Med Ctr, Div Pulm & Crit Care Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
bedaquiline; delamanid; multidrug-resistant tuberculosis; expert committee; TUBERCULOSIS; BEDAQUILINE; DELAMANID;
D O I
10.5588/ijtld.22.0343
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: This was a nationwide cohort study.O B J E C T I V E : To assess the treatment outcomes in patients with multidrug-resistant TB (MDR-TB) who underwent treatment guided by a national TB expert review committee in South Korea.DESIGN: We enrolled all patients with MDR-TB submitted for approval for the use of new TB drugs, including bedaquiline and delamanid, from 2016 to 2019. Patients were classified into two groups: those on new TB drugs and those not on new TB drugs. We compared the final treatment outcomes between the groups and analysed the prognostic factors.RES U LT S : Of a total of 785 patients, respectively 754 (96.1%) and 31 (3.9%) were classified into the "new TB drugs' group and "no new TB drugs"group. The new TB drugs group had a higher acid-fast bacilli smear positivity rate and higher resistance rate to second-line injectable drugs or fluoroquinolones. Of all the patients, 97.8% achieved culture conversion (97.7% vs. 100%), and 80.4% achieved treatment success (80.2% vs. 86.7%); there was no difference between the two groups.O N C L U S I O N S : New drugs are currently recommend-ed for use in all MDR-TB treatment regimens, and the use of new drugs, as determined by an expert committee, in mainly quinolone-susceptible MDR-TB, did not compromise the treatment success rate.
引用
收藏
页码:55 / +
页数:7
相关论文
共 29 条
[1]   Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis [J].
Ahmad, Nafees ;
Ahuja, Shama D. ;
Akkerman, Onno W. ;
Alffenaar, Jan-Willem C. ;
Anderson, Laura F. ;
Baghaei, Parvaneh ;
Bang, Didi ;
Barry, Pennan M. ;
Bastos, Mayara L. ;
Behera, Digamber ;
Benedetti, Andrea ;
Bisson, Gregory P. ;
Boeree, Martin J. ;
Bonnet, Maryline ;
Brode, Sarah K. ;
Brust, James C. M. ;
Cai, Ying ;
Caumes, Eric ;
Cegielski, J. Peter ;
Centis, Rosella ;
Chan, Pei-Chun ;
Chan, Edward D. ;
Chang, Kwok-Chiu ;
Charles, Macarthur ;
Cirule, Andra ;
Dalcolmo, Margareth Pretti ;
D'Ambrosio, Lia ;
de Vries, Gerard ;
Dheda, Keertan ;
Esmail, Aliasgar ;
Flood, Jennifer ;
Fox, Gregory J. ;
Frechet-Jachym, Mathilde ;
Fregona, Geisa ;
Gayoso, Regina ;
Gegia, Medea ;
Gler, Maria Tarcela ;
Gu, Sue ;
Guglielmetti, Lorenzo ;
Holtz, Timothy H. ;
Hughes, Jennifer ;
Isaakidis, Petros ;
Jarlsberg, Leah ;
Kempker, Russell R. ;
Keshavjee, Salmaan ;
Khan, Faiz Ahmad ;
Kipiani, Maia ;
Koenig, Serena P. ;
Koh, Won-Jung ;
Kritski, Afranio .
LANCET, 2018, 392 (10150) :821-834
[2]  
[Anonymous], 2017, Wkly Epidemiol Rec, V92, P749
[3]  
[Anonymous], 2017, World Health Statistics 2017: Monitoring Health for The SDGs, DOI DOI 10.1017/CBO9781107415324.004
[4]   Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study [J].
Borisov, Sergey E. ;
Dheda, Keertan ;
Enwerem, Martin ;
Leyet, Rodolfo Romero ;
D'Ambrosio, Lia ;
Centis, Rosella ;
Sotgiu, Giovanni ;
Tiberi, Simon ;
Alffenaar, Jan-Willem ;
Maryandyshev, Andrey ;
Belilovski, Evgeny ;
Ganatra, Shashank ;
Skrahina, Alena ;
Akkerman, Onno ;
Aleksa, Alena ;
Amale, Rohit ;
Artsukevich, Janina ;
Bruchfeld, Judith ;
Caminero, Jose A. ;
Carpena Martinez, Isabel ;
Codecasa, Luigi ;
Dalcolmo, Margareth ;
Denholm, Justin ;
Douglas, Paul ;
Duarte, Raquel ;
Esmail, Aliasgar ;
Fadul, Mohammed ;
Filippov, Alexey ;
Forsman, Lina Davies ;
Gaga, Mina ;
Garcia-Fuertes, Julia-Amaranta ;
Garcia-Garcia, Jose-Maria ;
Gualano, Gina ;
Jonsson, Jerker ;
Kunst, Heinke ;
Lau, Jillian S. ;
Mastrapa, Barbara Lazaro ;
Troya, Jorge Lazaro Teran ;
Manga, Selene ;
Manika, Katerina ;
Gonzalez Montaner, Pablo ;
Mullerpattan, Jai ;
Oelofse, Suzette ;
Ortelli, Martina ;
Juan Palmero, Domingo ;
Palmieri, Fabrizio ;
Papalia, Antonella ;
Papavasileiou, Apostolos ;
Payen, Marie-Christine ;
Pontali, Emanuele .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
[5]   Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond [J].
D'Ambrosio, L. ;
Bothamley, G. ;
Caminero Luna, J. A. ;
Duarte, R. ;
Guglielmetti, L. ;
Munoz Torrico, M. ;
Payen, M. C. ;
Saavedra Herrera, N. ;
Salazar Lezama, M. A. ;
Skrahina, A. ;
Tadolini, M. ;
Tiberi, S. ;
Veziris, N. ;
Migliori, G. B. .
PULMONOLOGY, 2018, 24 (02) :132-141
[6]   World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions [J].
Di Angelantonio, Emanuele ;
Kaptoge, Stephen ;
Pennells, Lisa ;
De Bacquer, Dirk ;
Cooney, Marie Therese ;
Kavousi, Maryam ;
Stevens, Gretchen ;
Riley, Leanne ;
Savin, Stefan ;
Altay, Servet ;
Amouyel, Philippe ;
Assmann, Gerd ;
Bell, Steven ;
Ben-Shlomo, Yoav ;
Berkman, Lisa ;
Beulens, Joline W. ;
Bjorkelund, Cecilia ;
Blaha, Michael J. ;
Blazer, Dan G. ;
Bolton, Thomas ;
Bonita, Ruth ;
Brenner, Beaglehole Hermann ;
Brunner, Eric J. ;
Casiglia, Edoardo ;
Chamnan, Parinya ;
Choi, Yeun-Hyang ;
Chowdhury, Rajiv ;
Coady, Sean ;
Crespo, Carlos J. ;
Cushman, Mary ;
Dagenais, Gilles R. ;
D'Agostino, Ralph B. ;
Daimon, Makoto ;
Davidson, Karina W. ;
Engstrom, Gunnar ;
Fang, Xianghua ;
Ford, Ian ;
Gallacher, John ;
Gansevoort, Ron T. ;
Gaziano, Thomas Andrew ;
Giampaoli, Simona ;
Grandits, Greg ;
Grimsgaard, Sameline ;
Grobbee, Diederick E. ;
Gudnason, Vilmundur ;
Guo, Qi ;
Humphries, Steve ;
Iso, Hiroyasu ;
Jukema, J. Wouter ;
Kauhanen, Jussi .
LANCET GLOBAL HEALTH, 2019, 7 (10) :E1332-E1345
[7]   Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline [J].
Diacon, Andreas H. ;
Pym, Alexander ;
Grobusch, Martin P. ;
de los Rios, Jorge M. ;
Gotuzzo, Eduardo ;
Vasilyeva, Irina ;
Leimane, Vaira ;
Andries, Koen ;
Bakare, Nyasha ;
De Marez, Tine ;
Haxaire-Theeuwes, Myriam ;
Lounis, Nacer ;
Meyvisch, Paul ;
De Paepe, Els ;
van Heeswijk, Rolf P. G. ;
Dannemann, Brian .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08) :723-732
[9]  
Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433
[10]   Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries [J].
Guenther, Gunar ;
van Leth, Frank ;
Alexandru, Sofia ;
Altet, Neus ;
Avsar, Korkut ;
Bang, Didi ;
Barbuta, Raisa ;
Bothamley, Graham ;
Ciobanu, Ana ;
Crudu, Valeriu ;
Danilovits, Manfred ;
Dedicoat, Martin ;
Duarte, Raquel ;
Gualano, Gina ;
Kunst, Heinke ;
de lange, Wiel ;
Leimane, Vaira ;
McLaughlin, Anne-Marie ;
Magis-Escurra, Cecile ;
Muylle, Inge ;
Polcova, Veronika ;
Popa, Cristina ;
Rumetshofer, Rudolf ;
Skrahina, Alena ;
Solodovnikova, Varvara ;
Spinu, Victor ;
Tiberi, Simon ;
Viiklepp, Piret ;
Lange, Christoph .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (03) :379-386